Therapeutic Antibodies

Subscribe to
our newsletters!

Showing 41–44 of 44 results

  • On the same day of purchase
    Ranibizumab (Lucentis) Biosimilars Pipeline Review
    This product provides basic information on approved drugs and drug candidates in R&D as biosimilar antibodies of Lucentis (ranibizumab)
    € 300.00
  • On the same day of purchase
    Aflibercept (Eylea) Biosimilars Pipeline Review
    This product provides basic information on drug candidates in R&D as biosimilar antibodies of Eylea (aflibercept)
    € 300.00
  • On the same day of purchase
    Ustekinumab (Stelara) Biosimilars Pipeline Review
    This product provides basic information on approved drugs and drug candidates in R&D as biosimilar antibodies of Stelara (ustekinumab).
    € 300.00
  • On the same day of purchase
    TSLP Pipeline Review
    This product provides basic information on approved drugs and drug candidates in R&D targeting thymic stromal lymphopoietin (TSLP) or its receptor (TSLP-R).
    € 300.00